Delivery Order SPE2DB22D1041-SPE2DB25FUCD7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $3,733.05. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,826.54. This is a firm fixed-price delivery order with an ultimate completion date of July 3, 2025, and represents a non-competitive set-aside. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.92 to AmerisourceBergen Drug Corp for the supply of Rifampin 150 mg capsules (30-count) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed price terms and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,562.44 delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,051.98 for 60 capsules of Rifampin 300 mg on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitive award, issued under firm fixed pricing, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,516.87 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract. The award was issued on June 20, 2025, with an ultimate completion date of June 23, 2025. This non-set-aside competitive award represents a routine pharmaceutical procurement through DLA's medical supply chain, with performance to occur at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $68,123.33 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100s). This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 11, 2025. The award was made without a set-aside designation, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.48 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count). The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with an ultimate completion date of August 14, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100-count), with a contract ceiling value of $28,600.52. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement supporting federal pharmaceutical supply needs. The work will be performed at AmerisourceBergen's corporate...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCD7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rifampin 300 mg capsules (60-count units) valued at $41,479.72 under a firm fixed price contract type. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a competitive procurement with no set-aside designation. Performance of this pharmaceutical supply contract will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contracting history demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through competitive selection, positioning it as a critical vendor within the federal medical supply chain for defense and military healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.5k | 9/18/25 |